1. Home
  2. CLDX vs PINC Comparison

CLDX vs PINC Comparison

Compare CLDX & PINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • PINC
  • Stock Information
  • Founded
  • CLDX N/A
  • PINC 2013
  • Country
  • CLDX United States
  • PINC United States
  • Employees
  • CLDX N/A
  • PINC N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PINC Other Consumer Services
  • Sector
  • CLDX Health Care
  • PINC Consumer Discretionary
  • Exchange
  • CLDX Nasdaq
  • PINC Nasdaq
  • Market Cap
  • CLDX 1.6B
  • PINC 1.8B
  • IPO Year
  • CLDX 2008
  • PINC 2013
  • Fundamental
  • Price
  • CLDX $24.50
  • PINC $26.51
  • Analyst Decision
  • CLDX Strong Buy
  • PINC Hold
  • Analyst Count
  • CLDX 9
  • PINC 6
  • Target Price
  • CLDX $46.13
  • PINC $25.17
  • AVG Volume (30 Days)
  • CLDX 1.6M
  • PINC 1.8M
  • Earning Date
  • CLDX 11-05-2025
  • PINC 11-04-2025
  • Dividend Yield
  • CLDX N/A
  • PINC 3.18%
  • EPS Growth
  • CLDX N/A
  • PINC N/A
  • EPS
  • CLDX N/A
  • PINC 0.22
  • Revenue
  • CLDX $5,790,000.00
  • PINC $1,012,647,000.00
  • Revenue This Year
  • CLDX N/A
  • PINC N/A
  • Revenue Next Year
  • CLDX N/A
  • PINC $1.86
  • P/E Ratio
  • CLDX N/A
  • PINC $117.74
  • Revenue Growth
  • CLDX N/A
  • PINC N/A
  • 52 Week Low
  • CLDX $14.40
  • PINC $17.23
  • 52 Week High
  • CLDX $47.00
  • PINC $28.79
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 57.57
  • PINC 62.57
  • Support Level
  • CLDX $22.44
  • PINC $26.43
  • Resistance Level
  • CLDX $25.51
  • PINC $27.09
  • Average True Range (ATR)
  • CLDX 1.22
  • PINC 0.65
  • MACD
  • CLDX 0.20
  • PINC -0.08
  • Stochastic Oscillator
  • CLDX 75.78
  • PINC 38.55

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About PINC Premier Inc.

Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.

Share on Social Networks: